Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells in Mullerian duct regression

Harvard University, Cambridge, Massachusetts, United States
Development (Impact Factor: 6.46). 07/2006; 133(12):2359-69. DOI: 10.1242/dev.02383
Source: PubMed


Examination of Müllerian inhibiting substance (MIS) signaling in the rat in vivo and in vitro revealed novel developmental stage- and tissue-specific events that contributed to a window of MIS responsiveness in Müllerian duct regression. The MIS type II receptor (MISRII)-expressing cells are initially present in the coelomic epithelium of both male and female urogenital ridges, and then migrate into the mesenchyme surrounding the male Müllerian duct under the influence of MIS. Expression of the genes encoding MIS type I receptors, Alk2 and Alk3, is also spatiotemporally controlled; Alk2 expression appears earlier and increases predominantly in the coelomic epithelium, whereas Alk3 expression appears later and is restricted to the mesenchyme, suggesting sequential roles in Müllerian duct regression. MIS induces expression of Alk2, Alk3 and Smad8, but downregulates Smad5 in the urogenital ridge. Alk2-specific small interfering RNA (siRNA) blocks both the transition of MISRII expression from the coelomic epithelium to the mesenchyme and Müllerian duct regression in organ culture. Müllerian duct regression can also be inhibited or accelerated by siRNA targeting Smad8 and Smad5, respectively. Thus, the early action of MIS is to initiate an epithelial-to-mesenchymal transition of MISRII-expressing cells and to specify the components of the receptor/SMAD signaling pathway by differentially regulating their expression.

1 Follower
5 Reads
  • Source
    • "The development of the M€ ullerian ducts occurs in three phases (Orvis and Behringer, 2007). Initially, there is a placode-like thickening of the coelomic epithelium, characterized by the expression of LIM1 and anti-M€ ullerian hormone receptor type II (AMHR-II) (Zhan et al., 2006; Arango et al., 2008). In the second phase, these primordial M€ ullerian cells invaginate from the coelomic epithelium to reach the Wolffian duct, induced by WNT4 expression from the mesonephros or coelomic epithelium (Vainio et al., 1999; Kobayashi et al., 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The birth of a baby with malformations of the genitalia urges medical action. Even in cases where the condition is not life-threatening, the identification of the external genitalia as male or female is emotionally essential for the family, and genital malformations represent one of the most stressful situations around a newborn. The female or male configuration of the genitalia normally evolves during fetal life according to the genetic, gonadal, and hormonal sex. Disorders of sex development occur when male hormone (androgens and anti-Müllerian hormone) secretion or action is insufficient in the 46,XY fetus or when there is an androgen excess in the 46,XX fetus. However, sex hormone defects during fetal development cannot explain all congenital malformations of the reproductive tract. This review is focused on those congenital conditions in which gonadal function and sex hormone target organ sensitivity are normal and, therefore, not responsible for the genital malformation. Furthermore, because the reproductive and urinary systems share many common pathways in embryo-fetal development, conditions associating urogenital malformations are discussed. Birth Defects Research (Part C), 2014. © 2014 Wiley Periodicals, Inc. © 2014 Wiley Periodicals, Inc.
    Birth Defects Research Part C Embryo Today Reviews 12/2014; 102(4). DOI:10.1002/bdrc.21086 · 2.63 Impact Factor
  • Source
    • "We and others have also shown that expression of the MIS type I receptors, is also spatiotemporally controlled, and that the SMAD1, 5 and 8 subfamily of intracellular signal transducers are involved in MD regression (Gouedard et al., 2000; Clarke et al., 2001; Visser et al., 2001; Zhan et al., 2006; Orvis et al., 2008). with SMAD8 being predominantly expressed over SMAD1 and over SMAD5, which is poorly expressed during MD regression (Clarke et al., 2001; Zhan et al., 2006) One of the important unanswered questions in MD regression is how MISR2, which is expressed in the mesenchyme surrounding the MD but not in the MD epithelial cells at the time of regression (Baarends et al., 1994; di Clemente et al., 1994; Teixeira et al., 1996), induces apoptosis in the neighboring epithelial cells (Tsuji et al., 1992; Catlin et al., 1997; Allard et al., 2000). WNT/β-catenin signaling is known to be crucial for normal uterine development from the MDs in females (Kobayashi and Behringer 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A key event during mammalian sexual development is regression of the Müllerian ducts (MDs) in the bipotential urogenital ridges (UGRs) of fetal males, which is caused by the expression of Müllerian inhibiting substance (MIS) in the Sertoli cells of the differentiating testes. The paracrine signaling mechanisms involved in MD regression are not completely understood, particularly since the receptor for MIS, MISR2, is expressed in the mesenchyme surrounding the MD, but regression occurs in both the epithelium and mesenchyme. Microarray analysis comparing MIS signaling competent and Misr2 knockout embryonic UGRs was performed to identify secreted factors that might be important for MIS-mediated regression of the MD. A seven-fold increase in the expression of Wif1, an inhibitor of WNT/β-catenin signaling, was observed in the Misr2-expressing UGRs. Whole mount in situ hybridization of Wif1 revealed a spatial and temporal pattern of expression consistent with Misr2 during the window of MD regression in the mesenchyme surrounding the MD epithelium that was absent in both female UGRs and UGRs knocked out for Misr2. Knockdown of Wif1 expression in male UGRs by Wif1-specific siRNAs beginning on embryonic day 13.5 resulted in MD retention in an organ culture assay, and exposure of female UGRs to added recombinant human MIS induced Wif1 expression in the MD mesenchyme. Knockdown of Wif1 led to increased expression of β-catenin and its downstream targets TCF1/LEF1 in the MD mesenchyme and to decreased apoptosis, resulting in partial to complete retention of the MD. These results strongly suggest that WIF1 secretion by the MD mesenchyme plays a role in MD regression in fetal males.
    Developmental Biology 12/2013; 386(1). DOI:10.1016/j.ydbio.2013.12.015 · 3.55 Impact Factor
  • Source
    • "Since cumulus cells continue to proliferate at later stages of folliculogenesis, but mural cells do not (Hirshfield, 1986), FOXL2 may be involved in shaping and establishment of the different granulosa phenotypes that comprise the follicle during development. The differentiation-promoting activity of MIS is demonstrated in the mammalian model by the epithelial–mesenchymal transition that occurs during Müllerian duct regression in sexually differentiating males (Zhan et al., 2006). In medaka, the expression of mis has been associated with somatic cells that surround the primordial germ cells (PGCs) of both sexes starting approximately four days before proliferative activity (Shiraishi et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The products of dax1, foxl2a and mis have each been shown to have proliferative and/or differentiative activities during mammalian organogenesis. These factors also play a role in regulating the biosynthesis of estrogen, particularly by modulating the activity of aromatase cyp19a. We demonstrate the transcription and translation of these genes during salmon embryogenesis. We were able to track sex-specific differences in these processes through accurate determination of the sex of each embryo and larva examined from genotyped microsatellites. We detected sex- and stage-specific immunolabeling of the embryonic gut, kidney, gonads, neural cord and skeletal muscle by DAX-1, FOXL2A and MIS. These results indicate the potential of these factors to mediate proliferation and/or differentiation programs during development of these tissues. As well, immunolabeling of skeletal muscle by CYP19B1 throughout the study reveals probable neurogenic activity associated with peripheral radial glial cells and the growing embryonic musculature.
    Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 11/2013; 168(1). DOI:10.1016/j.cbpb.2013.11.004 · 1.55 Impact Factor
Show more


5 Reads
Available from